与「OncoAlertAF」相关的搜索结果

📌FDA approves palbociclib with trastuzumab, with or without pertuzumab, and endocrine therapy for the maintenance treatment of HR-positive, HER2-positive metastatic breast cancer @OncoAlert #OncoAlertAF#

Introducing #APCCC26# Live from Lugano🇨🇭Brought to you from APCCC together with @OncoAlert 🚨 Triplet vs Doublet Therapy in Metastatic Hormone-Sensitive Prostate Cancer | APCCC 2026 Expert Discussion Join Dr. Jones, Dr. Rathkopf, and Dr. Fizazi for an expert discussion on one of the most rapidly evolving questions in genitourinary oncology: the optimal treatment approach for patients with metastatic hormone-sensitive prostate cancer (mHSPC). Series Faculty @BertrandTOMBAL @ChrisSweens1 @jmmrad @drjefstathiou @CaPsurvivorship @LoebStacy @charlesryanmd @AarmstrongDuke @Ecastromarcos @LVM_Walz @piet_ost @Nicola_Fossati @AnthonyMJoshua @Prof_Nick_James @VedangMurthy @AttardLab @Silke_Gillessen @AOmlin Pinging @AmandaNizamMD @scocmem @nataliagandur @gu_onc @tompowles1 @brian_rini @declangmurphy @cdanicas @neerajaiims